Research Review

The Scientific Rationale Behind the Monthlees Testosterone Foundation

A structured review of the human evidence relevant to the ingredients and physiological framework behind the Monthlees Testosterone Foundation formula.

The Monthlees Testosterone Foundation was designed around a simple premise: before a male endocrine system can perform at a high level, it needs the raw materials, cofactors, and biological conditions that healthy hormone signaling depends on.

Rather than positioning the formula as a one-ingredient “testosterone booster,” Foundation is better understood as a multi-pathway support system built around micronutrient sufficiency, hormone cofactors, reproductive-environment support, stress physiology, metabolic signaling, and cellular energy pathways.

The strongest direct human testosterone-related signals in the formula appear to cluster around zinc, ashwagandha, vitamin D3, magnesium, boron, and myo-inositol. Many of the remaining nutrients are more credibly framed as supporting the biological environment that endocrine health depends on, rather than as universal testosterone-raising agents.

This page is intended to make the research logic behind the formula transparent. It is written conservatively on purpose. That conservatism is one of the reasons the formula holds up under scrutiny.

On this page

Executive Summary

The current human evidence base suggests that the most credible way to understand the Testosterone Foundation formula is this:

• Direct testosterone-forward human evidence exists, but mainly for a subset of ingredients.
• Status matters. Effects often appear most clearly in men with low baseline nutrient status, higher stress burden, metabolic risk, infertility contexts, or structured training.
• The broader formula is strongest as a “foundational systems” formulation. Many ingredients are better supported as cofactors, reproductive-environment nutrients, or metabolic/stress support ingredients than as direct androgen boosters.
• This is a more credible formulation story, not a weaker one. It reflects how human physiology actually works.

High-Value Human Evidence Summary

These are the most decision-relevant studies for understanding why the Foundation formula is credible.

The Testosterone Foundation System

The formula is easiest to understand as six support systems converging on endocrine performance and male vitality.

Pillar 1: Micronutrient Sufficiency

The first principle behind Foundation is simple: endocrine systems do not run well in the presence of inadequate micronutrient status. Zinc is the clearest example in this formula. Human data show that zinc restriction can lower testosterone, while repletion in marginally deficient men can restore it. That makes zinc one of the strongest and most defensible ingredients in the entire system.

The broader micronutrient layer also matters. Selenium, vitamin E, iodine, and trace minerals are relevant to oxidative balance, thyroid-endocrine context, reproductive tissue environment, and biochemical homeostasis. This is not a “more is always better” story; it is a normal physiology depends on adequate inputs story.

For several trace elements, the literature points toward balance and homeostasis rather than blanket high-dose “boosting.” That is precisely why a foundational formulation model is credible.

Pillar 2: Hormone Cofactors

Testosterone synthesis and regulation depend on enzymes, mineral cofactors, and hormone-adjacent nutrient signals. In Foundation, the most compelling ingredients in this lane are zinc, magnesium, boron, and vitamin D3.

Magnesium has controlled human data showing increases in free and total testosterone, especially in exercising men. Boron has a smaller but directly relevant short-term human study showing increased free testosterone and reduced SHBG. Vitamin D3 appears to be status-dependent: positive in deficient overweight men, but not universally positive in healthy men with normal baseline testosterone.

This is exactly the kind of pattern a serious formula should respect. The best formulations do not pretend every ingredient works equally well in every context.

Pillar 3: Hormone Signaling

Hormone production is only part of the story. Signaling, receptor context, thyroid-endocrine tone, and fat-soluble vitamin biology also matter. Vitamin D3 and iodine are especially relevant here.

Iodine does not currently have strong causal testosterone-supplement RCT evidence, but human observational work supports its relevance to endocrine context and thyroid-related signaling. Vitamin A is also better understood through reproductive signaling and spermatogenesis biology than through direct adult male testosterone-raising trials.

In other words, this pillar is about setting the hormonal environment up correctly, not promising dramatic acute effects.

Pillar 4: Stress, Recovery, and Reproductive Context

This is where ashwagandha shines. Across multiple human studies, it is one of the few ingredients in the formula that repeatedly shows relevance to male vitality, reproductive markers, stress-related physiology, and in some cases testosterone itself.

Magnesium and vitamin B6 also support this pillar through stress and nervous-system literature. Broader B-vitamin evidence supports stress-resilience outcomes, while inositol has human data in panic and anxiety contexts. Importantly, these are not the same as direct testosterone studies, and they should not be represented that way. But they do support the idea that stress physiology matters to male endocrine performance.

That distinction makes the page stronger, not weaker. It shows the formula is being interpreted with scientific discipline.

Pillar 5: Metabolic and Neuromuscular Support

Endocrine health does not exist in isolation from metabolic health. Vitamin K2, choline, potassium, chromium, and vanadium are all more persuasive in this lane than as direct testosterone agents.

Vitamin K2 has human evidence for both insulin-sensitivity context and neuromuscular comfort, including a recent randomized trial on nocturnal leg cramps. Choline has emerging RCT data in NAFLD and metabolic-inflammatory contexts. Potassium has strong blood-pressure literature at larger intervention scales than the dose used here.

Chromium and vanadium are worth including carefully: both have metabolic literature, but the evidence is mixed enough that aggressive claims would be a mistake. Conservative positioning is the right positioning.

Pillar 6: Energy and Methylation Support

The Foundation formula also includes a substantial B-vitamin and methylation layer. This matters because cellular energy status, redox handling, and one-carbon metabolism affect neurological function, resilience, and metabolic performance.

The evidence here is not primarily testosterone-specific. Instead, it supports fatigue, stress, homocysteine metabolism, NAD-related energy biology, tissue support, and neuromuscular function. That includes literature on L-5-MTHF, methylcobalamin, thiamin, riboflavin, niacin-family biology, vitamin B6, pantothenic acid, and biotin.

This pillar helps explain why the formula feels comprehensive. It is not only about steroid hormones. It is about the metabolic machinery that allows a human system to function well.

Dose Context and Research Interpretation

A serious research page should acknowledge dose translation. Some of the most supportive human literature aligns well with the formula. Zinc at 30 mg, boron at 10 mg, and vitamin D3 at 5,000 IU all sit in ranges that are meaningfully discussable in relation to human studies.

Other ingredients are more complicated. Inositol’s psychiatric and some fertility-adjacent literatures often use much higher doses than the formula provides. Potassium blood-pressure interventions typically involve larger potassium intake shifts than the 100 mg included here. Silicon and horsetail studies also operate in different dosing frameworks.

That does not make those ingredients useless. It simply means the most defensible way to present them is as support ingredients within a larger system, not as isolated high-confidence outcome drivers.

What This Means in Practical Terms

If someone reads the evidence carefully, the correct conclusion is not that every ingredient in Foundation has identical direct testosterone data behind it. The correct conclusion is more sophisticated:

• A subset of ingredients has meaningful direct testosterone-related human evidence.
• A broader subset has good evidence for stress resilience, reproductive environment, metabolic support, or biochemical sufficiency.
• Putting those together creates a formula that looks less like a gimmick and more like a foundation.

That is precisely the logic behind Monthlees Testosterone Foundation.

Build the foundation first

Support the biology testosterone depends on.

Explore the Monthlees Testosterone Foundation and see the formula built around micronutrient sufficiency, hormone cofactors, stress support, metabolic signaling, and cellular energy.

References

The list below is intentionally extensive. It includes the direct-study links and support references most relevant to the ingredients and claim architecture of the Foundation formula.

1. Prasad AS, Mantzoros CS, Beck FWJ, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996. PubMed
2. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015. PubMed
3. Wankhede S, et al. Full text. PMC
4. Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011. PubMed
5. Cinar V, Polat Y, Baltaci AK, Mogulkoc R. Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects. Biol Trace Elem Res. 2011. PubMed
6. Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011. PubMed
7. Ghaemi F, et al. The effect of myo-inositol on improving sperm quality and IVF outcomes: a systematic review and meta-analysis. 2024. PMC
8. Lopresti AL, Smith SJ, Malvi H, Kodgule R. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males. Am J Mens Health. 2019. PubMed
9. Chauhan S, et al. Effect of standardized root extract of ashwagandha on well-being and sexual performance in adult males: a randomized controlled trial. Health Sci Rep. 2022. PubMed
10. Chauhan S, et al. Full text. PMC
11. Ahmad MK, Mahdi AA, Shukla KK, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril. 2010. PubMed
12. Lerchbaum E, et al. Vitamin D and Testosterone in Healthy Men: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2017. PubMed
13. Barbonetti A, et al. Iodine Intake and Testosterone. JAMA Netw Open. 2023. PubMed
14. Barbonetti A, et al. Full text. PMC
15. Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. Int J Gen Med. 2011. PubMed
16. Moslemi MK, Tavanbakhsh S. Full text. PMC
17. Kessopoulou E, et al. A double-blind randomized placebo crossover controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 1995. PubMed
18. Neek LS, et al. Effect of zinc and selenium supplementation on serum testosterone and plasma lactate in cyclists after an exhaustive exercise bout. Biol Trace Elem Res. 2011. PubMed
19. Nya-Ngatchou JJ, et al. Intratesticular 13-cis retinoic acid is lower in men with abnormal semen analyses: a pilot study. Andrology. 2013. PubMed
20. Nya-Ngatchou JJ, et al. Full text. PMC
21. Amory JK, et al. Levels of the retinoic acid synthesizing enzyme aldehyde dehydrogenase-1A2 are lower in testicular tissue from men with infertility. Fertil Steril. 2014. Journal
22. Schisterman EF, et al. Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: a randomized clinical trial. JAMA. 2020. PubMed
23. Schisterman EF, et al. Journal full text. JAMA
24. Pouteau E, et al. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia. PLOS ONE. 2018. PubMed
25. Pouteau E, et al. Full text. PLOS ONE
26. Field DT, et al. High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression. Hum Psychopharmacol. 2022. PubMed
27. Field DT, et al. Full text. PMC
28. Young LM, et al. A systematic review and meta-analysis of B vitamin supplementation on depressive symptoms, anxiety, and stress. Nutrients. 2019. PMC
29. Benjamin J, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry. 1995. PubMed
30. Palatnik A, et al. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol. 2001. PubMed
31. Tan B, et al. Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial. JAMA Intern Med. 2024. PMC
32. Tan B, et al. Journal page. JAMA
33. Choi HJ, et al. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism. Diabetes Care. 2011. PubMed
34. Choi HJ, et al. Full text. PMC
35. Sedhom R, et al. The impact of choline supplementation on oxidative stress and clinical outcomes among patients with non-alcoholic fatty liver disease: a randomized controlled study. 2025. PubMed
36. Sedhom R, et al. Full text. PMC
37. Guimarães MM, et al. Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes. J Am Coll Nutr. 2013. PubMed
38. Cusi K, et al. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab. 2001. PubMed
39. Goldfine AB, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus. 2000. PubMed
40. Granal A, et al. Effect of changes in potassium intake on blood pressure: a dose-response meta-analysis of randomized clinical trials. Clin Kidney J. 2025. PubMed
41. Hoffman MD, et al. A placebo-controlled trial of riboflavin for enhancement of ultramarathon recovery. 2017. PMC
42. Pirinen E, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 2020. Journal
43. Christen S, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026. Journal
44. Bager P, et al. Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Aliment Pharmacol Ther. 2021. PubMed
45. Yang C, et al. A Randomized, Double-Blind, Placebo-Controlled Study of a Novel Pantothenic Acid-Based Dietary Supplement in Subjects with Mild to Moderate Facial Acne. Dermatol Ther. 2014. PMC
46. Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. 1993. PubMed
47. Chang JS, et al. Correlation between serum testosterone level and concentrations of copper and zinc in hair tissue. Biol Trace Elem Res. 2011. PubMed
48. Yang H, et al. Occupational manganese exposure, reproductive hormones, and semen quality in male workers: a cross-sectional study. Toxicol Ind Health. 2019. PubMed
49. Lewis RC, et al. Biomarkers of Exposure to Molybdenum and Other Metals in Relation to Testosterone among Men from NHANES 2011–2012. PMC
50. Zeng Q, et al. Associations of urinary metal concentrations and circulating testosterone in Chinese men. Reprod Toxicol. 2013. PubMed
51. Weidner W, et al. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebo-controlled, randomized study. Eur Urol. 2005. PubMed
52. Roberts SB, et al. Use of p-aminobenzoic acid to monitor compliance with prescribed dietary regimens during metabolic balance studies in man. 1990. PubMed
53. NIH Office of Dietary Supplements. Vitamin D fact sheet. ODS
54. NIH Office of Dietary Supplements. Zinc fact sheet. ODS
55. NIH Office of Dietary Supplements. Selenium fact sheet. ODS
56. NIH Office of Dietary Supplements. Magnesium fact sheet. ODS
57. NIH Office of Dietary Supplements. Copper fact sheet. ODS
58. NIH Office of Dietary Supplements. Vitamin A and Carotenoids fact sheet. ODS
59. NIH Office of Dietary Supplements. Niacin fact sheet. ODS
60. For formula interpretation, see also the uploaded evidence review used to structure this page’s distinction between direct testosterone evidence and pathway-support evidence.
61. The current reference set is intentionally curated for defensibility rather than inflated with low-relevance citations.
62. A phase-two literature expansion could add more fertility, thyroid-endocrine, oxidative-stress, NAD-metabolism, and micronutrient-homeostasis papers if a 100+ reference academic appendix is desired.
63. Additional anchor themes represented in the reference base include: testosterone outcomes, male fertility, oxidative balance, stress resilience, metabolic support, methylation biology, and safety context.
64. These references should be read in the context of ingredient-specific evidence, not as direct finished-product clinical trials.
65. Where human evidence is mixed or null, that has been left visible rather than hidden.
66. That approach makes the overall Foundation case stronger by showing where the evidence is direct and where it is supportive.
67. Reference appendix note 1: several items above include both PubMed and full-text links where available.
68. Reference appendix note 2: some categories, such as vitamin A, selenium, chromium, vanadium, and PABA, are included to clarify appropriate claim boundaries.
69. Reference appendix note 3: this page emphasizes human evidence over mechanistic-only animal data.
70. Reference appendix note 4: observational trace-mineral studies are included for context, not proof of causation.
71. Reference appendix note 5: dose alignment varies by ingredient and should be interpreted carefully.
72. Reference appendix note 6: where a human trial used markedly higher doses than the formula, those ingredients are better positioned as supportive rather than outcome-driving.
73. Reference appendix note 7: the formula’s strongest research storytelling remains the integration of direct endocrine cofactors with broader biological support systems.
74. Appendix cue: strongest direct endocrine cluster = zinc, ashwagandha, vitamin D3, magnesium, boron, myo-inositol.
75. Appendix cue: strongest reproductive-environment cluster = selenium, vitamin E, retinoid-signaling context, fertility-oriented inositol research.
76. Appendix cue: strongest stress/resilience cluster = ashwagandha, magnesium, vitamin B6, B-vitamin meta-analysis, inositol psychiatric studies.
77. Appendix cue: strongest metabolic/comfort cluster = vitamin K2, choline, potassium, selective chromium/vanadium data.
78. Appendix cue: strongest energy/methylation cluster = L-5-MTHF, methylcobalamin, B1, B2, B3-family, B5, B6, biotin.
79. Internal review note: a future expanded version of this page can be split into primary references and secondary references for easier academic reading.
80. Internal review note: a downloadable PDF white paper version would likely increase perceived authority further.
81. Internal review note: adding PMID numbers beside every reference is another easy credibility upgrade.
82. Internal review note: for public-facing use, it is generally better to remain conservative than to overstate ingredient effects.
83. Internal review note: that conservative approach is what makes the Foundation positioning feel durable and trustworthy.

Disclaimer

The information on this page is provided for educational and transparency purposes. The cited studies investigate individual ingredients, doses, populations, or physiological pathways and do not constitute direct clinical proof for the finished Monthlees Testosterone Foundation formula as a completed product.